Suppr超能文献

血管活性肠肽(VIP)和胰高血糖素高亲和力受体以及VIP低亲和力结合蛋白(已证明与钙调蛋白相同)的同时溶解。

Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin.

作者信息

Andersson M, Carlquist M, Maletti M, Marie J C

机构信息

Department of Biochemistry II, Karolinska Institute, Stockholm, Sweden.

出版信息

FEBS Lett. 1993 Feb 22;318(1):35-40. doi: 10.1016/0014-5793(93)81322-q.

Abstract

Anion-exchange chromatography of solubilized pig liver cell membranes on DEAE-Sepharose gave a fraction with high affinity binding proteins for VIP and glucagon distinct from each other. Scatchard analysis indicated the presence of one binding site for VIP (Kd 1.5 +/- 0.6 nM and Bmax 1.3 +/- 0.4 pmol/mg). The order of potency for VIP-related peptides to inhibit [125I]VIP binding was: VIP > peptide histidine isoleucine amide (PHI) > rat growth hormone releasing factor (rGRF) > secretin. GTP-gamma-S inhibited [125I]VIP binding and reduced the affinity of VIP binding sites to 6.5 nM. In the same isolated fraction, [125I]glucagon binding was displaced by glucagon preferentially to oxyntomodulin, and GTP did not affect this [125I]glucagon binding. Scatchard analysis indicated the presence of one binding site for glucagon (Kd 0.08 +/- 0.03 nM and Bmax 0.31 +/- 0.01 pmol/mg). A low-affinity VIP binding protein (IC50 0.7 microM) was detected in a fraction eluting later and exhibited a peptide specificity: rGRF > VIP > VIP(10-28) > secretin > PHI. This rGRF-preferring protein (18 kDa) was purified and had a partial amino-acid sequence identical to that of calmodulin. Its [125I]VIP binding was competitively inhibited by VIP and calmidazolium in a manner similar to that for pig brain calmodulin. Thus we have co-solubilized VIP and glucagon high affinity receptors from pig liver cell membranes and separated them from VIP-binding calmodulin.

摘要

用DEAE-琼脂糖对溶解的猪肝细胞膜进行阴离子交换层析,得到了对血管活性肠肽(VIP)和胰高血糖素有高亲和力结合蛋白的一个组分,二者相互不同。Scatchard分析表明存在一个VIP结合位点(解离常数Kd为1.5±0.6 nM,最大结合量Bmax为1.3±0.4 pmol/mg)。VIP相关肽抑制[125I]VIP结合的效力顺序为:VIP>肽组氨酸异亮氨酸酰胺(PHI)>大鼠生长激素释放因子(rGRF)>促胰液素。鸟苷三磷酸γ-硫酯(GTP-γ-S)抑制[125I]VIP结合,并将VIP结合位点的亲和力降低至6.5 nM。在同一分离组分中,[125I]胰高血糖素结合被胰高血糖素优先取代,而不是胃泌酸调节素,并且GTP不影响这种[125I]胰高血糖素结合。Scatchard分析表明存在一个胰高血糖素结合位点(Kd为0.08±0.03 nM,Bmax为0.31±0.01 pmol/mg)。在稍后洗脱的一个组分中检测到一种低亲和力VIP结合蛋白(半数抑制浓度IC50为0.7 μM),并表现出肽特异性:rGRF>VIP>VIP(10 - 28)>促胰液素>PHI。这种优先结合rGRF的蛋白(18 kDa)被纯化,其部分氨基酸序列与钙调蛋白相同。其[125I]VIP结合被VIP和钙调蛋白拮抗剂以类似于猪肝钙调蛋白的方式竞争性抑制。因此,我们从猪肝细胞膜中共溶解了VIP和胰高血糖素高亲和力受体,并将它们与结合VIP的钙调蛋白分离。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验